Company: ACCO
Filing Date: 2025-02-21
Form Type: 10-K
Source: 0000950170-25-024931
Chunk: 186

Company: ACCO BRANDS Corp
Filing Date: 2025-02-21
Form: 10-K
Item: Item 1B
Chunk 186
---
 goodwill impairment testing, will prove to be an accurate prediction of the future. If our assumptions regarding future performance are not achieved, or if future events occur that adversely affect our enterprise value, we may be required to record additional goodwill impairment charges in future periods. 

72

 ACCO Brands Corporation and SubsidiariesNotes to Consolidated Financial Statements (Continued) 

Changes in the net carrying amount of goodwill by segment were as follows:

        (in millions)
         
        ACCO Brands Americas

        ACCO Brands International

        Total

        Balance at December 31, 2022
         
        $
        472.2

        $
        199.3

        $
        671.5

        Goodwill impairment

        (89.5
        )

        —

        (89.5
        )

        Foreign currency translation

        0.9

        7.1

        8.0

        Balance at December 31, 2023
         
        $
        383.6

        $
        206.4

        $
        590.0

        Goodwill impairment

        (127.5
        )

        —

        (127.5
        )

        Foreign currency translation

        (2.8
        )

        (13.3
        )

        (16.1
        )

        Balance at December 31, 2024
         
        $
        253.3

        $
        193.1

        $
        446.4

       The goodwill balance includes $313.8 million, $403.3 million, and $530.8 million of accumulated impairment losses for the years ended December 31, 2022, 2023, and 2024, respectively. Identifiable Intangible Assets  We test indefinite-lived intangibles for impairment at least annually as of our measurement date of May 31st and on an interim basis if an event or circumstance indicates that it is more likely than not that an impairment loss has been incurred. During the second quarter of 2024, we identified a triggering event for our indefinite-lived trade names within our Americas reporting unit indicating that it was more likely than not that an impairment loss had been incurred. The triggering event was a decline in forecasted cash flows within certain product categories. Accordingly, as of May 31, 2024, we completed an impairment assessment, on a quantitative basis, for our indefinite